Skip to content
2000
Volume 26, Issue 8
  • ISSN: 1389-2010
  • E-ISSN: 1873-4316

Abstract

Fisetin is a bioactive compound found in numerous fruits and vegetables, including strawberries, apples, grapes, persimmon, cucumber, onion, . The compound is also well-known for its neurotrophic, anti-inflammatory, anti-carcinogenic, anti-diabetic, and other health-promoting properties. Although there is increasing agreement that it has therapeutic properties, but its poor water solubility, high lipophilicity, and lower oral bioavailability make it difficult to use clinically. Extensive research has attempted to overcome these restrictions by developing novel and superior delivery systems. Considering the diverse potential, this review is the first to summarise the available data on Fisetin to collate the information related to analytical methods, pharmacological action, their mechanisms, regulatory aspects, and toxicity profile. It also covers the marketed products, related clinical trials, and patent updates of the moiety. In addition, an endeavor has been attempted to discuss and assess the various drug delivery systems employed to increase the biological attributes of Fisetin. The presented manuscript is the first to present a compendium of up-to-date literature on all of the domains considered necessary for this type of natural molecule to carve down its path from being a mere dietary supplement to a promising therapeutic drug candidate. The manuscript is expected to benefit the researchers working on natural and bioactive compounds, industrial scientists, and the general population interested in Fesitin.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cpb/10.2174/0113892010304479240415074928
2024-04-22
2026-03-05

  • From This Site

    /content/journals/cpb/10.2174/0113892010304479240415074928
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Khan N. Syed D.N. Ahmad N. Mukhtar H. Fisetin: A dietary antioxidant for health promotion. Antioxid. Redox Signal. 2013 19 2 151 162 10.1089/ars.2012.4901 23121441
    [Google Scholar]
  2. Grynkiewicz G. Demchuk O.M. New perspectives for fisetin. Front Chem. 2019 7 October 697 10.3389/fchem.2019.00697 31750288
    [Google Scholar]
  3. Parveen R. Amalgamation of nanotechnology for delivery of bioactive constituents in solid tumors. Curr. Drug Deliv. 2022 20 5 457 482 35469568
    [Google Scholar]
  4. Eriksson K. Johanson J. Majkgård A. Sharma D.D. Experiential Knowledge and Cost in the Internationalization Process; Knowledge, Networks and Power: The Uppsala School of International Business., 2015 28 41 63
    [Google Scholar]
  5. Mohapatra S. Iqubal A. Ansari M.J. Jan B. Zahiruddin S. Mirza M.A. Ahmad S. Iqbal Z. Benefits of black cohosh (Cimicifuga racemosa) for women health: An up-close and in-depth review. Pharmaceuticals 2022 15 3 278 10.3390/ph15030278 35337076
    [Google Scholar]
  6. Sun X. Ma X. Li Q. Yang Y. Xu X. Sun J. Yu M. Cao K. Yang L. Yang G. Zhang G. Wang X. Anti cancer effects of fisetin on mammary carcinoma cells via regulation of the PI3K/Akt/mTOR pathway: In vitro and in vivo studies. Int. J. Mol. Med. 2018 42 2 811 820 10.3892/ijmm.2018.3654 29749427
    [Google Scholar]
  7. Ahmad A. Ali T. Park H.Y. Badshah H. Rehman S.U. Kim M.O. Neuroprotective effect of fisetin against amyloid-beta-induced cognitive/synaptic dysfunction, neuroinflammation, and neurodegeneration in adult Mice. Mol. Neurobiol. 2017 54 3 2269 2285 10.1007/s12035‑016‑9795‑4 26944285
    [Google Scholar]
  8. Jan B. Parveen R. Zahiruddin S. Khan M.U. Mohapatra S. Ahmad S. Nutritional constituents of mulberry and their potential applications in food and pharmaceuticals: A review. Saudi J. Biol. Sci. 2021 28 7 3909 3921 10.1016/j.sjbs.2021.03.056 34220247
    [Google Scholar]
  9. Chizhov A.V. Schmidt E. Knöll L. Welsch D.G. Two-pulse correlations in noisy quantum channels. Optika i Spektroskopiya. 2001 91 3 436 440
    [Google Scholar]
  10. Tilburt J. Kaptchuk T.J. Herbal medicine research and global health: An ethical analysis. Bull. World Health Organ. 2008 86 8 594 599 10.2471/BLT.07.042820 18797616
    [Google Scholar]
  11. Kumar R. Kumar R. Sharma N. Vyas M. Mahajan S. Satija S. Fisetin: A phytochemical with various pharmacological activities. Plant Arch. 2019 19 1012 1016
    [Google Scholar]
  12. Currais A. Farrokhi C. Dargusch R. Armando A. Quehenberger O. Schubert D. Maher P. Fisetin reduces the impact of aging on behavior and physiology in the rapidly aging SAMP8 mouse. J. Gerontol. A Biol. Sci. Med. Sci. 2018 73 3 299 307 10.1093/gerona/glx104 28575152
    [Google Scholar]
  13. Sabarwal A. Agarwal R. Singh R.P. Fisetin inhibits cellular proliferation and induces mitochondria‐dependent apoptosis in human gastric cancer cells. Mol. Carcinog. 2017 56 2 499 514 10.1002/mc.22512 27254419
    [Google Scholar]
  14. Park B.S. Choi N.E. Lee J.H. Kang H.M. Yu S.B. Kim H.J. Kang H.K. Kim I.R. Crosstalk between fisetin-induced apoptosis and autophagy in human oral squamous cell carcinoma. J. Cancer 2019 10 1 138 146 10.7150/jca.28500 30662534
    [Google Scholar]
  15. Al S.V. Harnessing the therapeutic potential of fisetin and its nanoparticles: Journey so far and road ahead. Chem. Biol. Interact. 2022 356 109869
    [Google Scholar]
  16. Guo P. Feng Y.Y. Anti-inflammatory effects of kaempferol, myricetin, fisetin and ibuprofen in neonatal rats. Trop. J. Pharm. Res. 2017 16 8 1819 1826 10.4314/tjpr.v16i8.10
    [Google Scholar]
  17. Elsallabi O. Patruno A. Pesce M. Cataldi A. Carradori S. Gallorini M. Fisetin as a senotherapeutic agent: Biopharmaceutical properties and crosstalk between cell senescence and neuroprotection. Molecules 2022 27 3 738 10.3390/molecules27030738 35164003
    [Google Scholar]
  18. Kirkland J.L. Tchkonia T. Senolytic drugs: From discovery to translation. J. Intern. Med. 2020 288 5 518 536 10.1111/joim.13141 32686219
    [Google Scholar]
  19. Mbara K.C. Devnarain N. Owira P.M.O. Potential role of polyphenolic flavonoids as senotherapeutic agents in degenerative diseases and geroprotection. Pharmaceut. Med. 2022 36 6 331 352 10.1007/s40290‑022‑00444‑w 36100824
    [Google Scholar]
  20. Zhu Y. Doornebal E.J. Pirtskhalava T. Giorgadze N. Wentworth M. Fuhrmann-Stroissnigg H. Niedernhofer L.J. Robbins P.D. Tchkonia T. Kirkland J.L. New agents that target senescent cells: The flavone, fisetin, and the BCL-XL inhibitors, A1331852 and A1155463. Aging (Albany NY) 2017 9 3 955 963 10.18632/aging.101202 28273655
    [Google Scholar]
  21. Allan J. Robinson R. CCCIX.—A new synthesis of fisetin and of quercetin. J. Chem. Soc. 1926 129 0 2334 2336 10.1039/JR9262902334
    [Google Scholar]
  22. Mohod S.M. Kandhare A.D. Bodhankar S.L. Gastroprotective potential of Pentahydroxy flavone isolated from Madhuca indica J. F. Gmel. leaves against acetic acid-induced ulcer in rats: The role of oxido-inflammatory and prostaglandins markers. J. Ethnopharmacol. 2016 182 150 159 10.1016/j.jep.2016.02.026 26906969
    [Google Scholar]
  23. Lall R.K. Adhami V.M. Mukhtar H. Dietary flavonoid fisetin for cancer prevention and treatment. Mol. Nutr. Food Res. 2016 60 6 1396 1405 10.1002/mnfr.201600025 27059089
    [Google Scholar]
  24. Prasath G.S. Subramanian S.P. Antihyperlipidemic effect of fisetin, a bioflavonoid of strawberries, studied in streptozotocin-induced diabetic rats. J. Biochem. Mol. Toxicol. 2014 28 10 442 449 10.1002/jbt.21583 24939606
    [Google Scholar]
  25. Imran M. Saeed F. Gilani S.A. Shariati M.A. Imran A. Afzaal M. Atif M. Tufail T. Anjum F.M. Fisetin: An anticancer perspective. Food Sci. Nutr. 2021 9 1 3 16 10.1002/fsn3.1872 33473265
    [Google Scholar]
  26. Prasath G.S. Sundaram C.S. Subramanian S.P. Fisetin averts oxidative stress in pancreatic tissues of streptozotocin-induced diabetic rats. Endocrine 2013 44 2 359 368 10.1007/s12020‑012‑9866‑x 23277230
    [Google Scholar]
  27. Syed D. Adhami V. Khan M. Mukhtar H. Inhibition of Akt/mTOR signaling by the dietary flavonoid fisetin. Anticancer. Agents Med. Chem. 2013 13 7 995 1001 10.2174/18715206113139990129 23293889
    [Google Scholar]
  28. Srinivasan R. Natarajan D. Subramaniam Shivakumar M. Nagamurugan N. Isolation of fisetin from elaeagnus indica Serv. Bull. (Elaeagnaceae) with antioxidant and antiproliferative activity. Free Radic. Antioxid. 2016 6 2 145 150 10.5530/fra.2016.2.3
    [Google Scholar]
  29. Syed D.N. Afaq F. Maddodi N. Johnson J.J. Sarfaraz S. Ahmad A. Setaluri V. Mukhtar H. Inhibition of human melanoma cell growth by the dietary flavonoid fisetin is associated with disruption of Wnt/β-catenin signaling and decreased Mitf levels. J. Invest. Dermatol. 2011 131 6 1291 1299 10.1038/jid.2011.6 21346776
    [Google Scholar]
  30. Arai Y. Watanabe S. Kimira M. Shimoi K. Mochizuki R. Kinae N. Dietary intakes of flavonols, flavones and isoflavones by Japanese women and the inverse correlation between quercetin intake and plasma LDL cholesterol concentration. J. Nutr. 2000 130 9 2243 2250 10.1093/jn/130.9.2243 10958819
    [Google Scholar]
  31. Yusif Shukurlu H. Shukurova Z.Y. Ismailova A. Ch. AFS. Ultraviolet and visible spectroscopy for the analysis of crude extract of cotinus coggygria (cotinus coggygria scop; anacardiaceae). Agric. Sci. 2020
    [Google Scholar]
  32. Aghofack-Nguemezi J. Schwab W. Differential accumulation of flavonoids by tomato (<i>Solanum lycopersicum</i>) fruits tissues during maturation and ripening. J. Appl. Biosci. 2015 84 1 7682 10.4314/jab.v84i1.2
    [Google Scholar]
  33. Masibo M. He Q. Major mango polyphenols and their potential significance to human health. Compr. Rev. Food Sci. Food Saf. 2008 7 4 309 319 10.1111/j.1541‑4337.2008.00047.x 33467788
    [Google Scholar]
  34. Panche A.N. Diwan A.D. Chandra S.R. Flavonoids: An overview. J. Nutr. Sci. 2016 5 e47 10.1017/jns.2016.41 28620474
    [Google Scholar]
  35. Kumar R. Kumar R. Khursheed R. Awasthi A. Khurana N. Singh S.K. Khurana S. Sharma N. Gunjal P. Kaur J. Corrie L. Development and validation of RP-HPLC method for estimation of fisetin in rat plasma. S. Afr. J. Bot. 2021 140 284 289 10.1016/j.sajb.2020.05.010
    [Google Scholar]
  36. Shyamal K. Bioactive flavonoid fisetin – A molecule of pharmacological interest. Signpost Open Access J Org Biomol Chem 2014 2 89 128
    [Google Scholar]
  37. Mehta P. Pawar A. Mahadik K. Bothiraja C. Emerging novel drug delivery strategies for bioactive flavonol fisetin in biomedicine. Biomed. Pharmacother. 2018 106 June 1282 1291 10.1016/j.biopha.2018.07.079 30119198
    [Google Scholar]
  38. Kashyap D. Sharma A. Sak K. Tuli H.S. Buttar H.S. Bishayee A. Fisetin: A bioactive phytochemical with potential for cancer prevention and pharmacotherapy. Life Sci. 2018 194 75 87 10.1016/j.lfs.2017.12.005 29225112
    [Google Scholar]
  39. Fiorani M. Accorsi A. Dietary flavonoids as intracellular substrates for an erythrocyte trans-plasma membrane oxidoreductase activity. Br. J. Nutr. 2005 94 3 338 345 10.1079/BJN20051504 16176603
    [Google Scholar]
  40. Campillo N. Viñas P. Martínez-Castillo N. Hernández-Córdoba M. Determination of volatile nitrosamines in meat products by microwave-assisted extraction and dispersive liquid–liquid microextraction coupled to gas chromatography–mass spectrometry. J. Chromatogr. A 2011 1218 14 1815 1821 10.1016/j.chroma.2011.02.010 21376329
    [Google Scholar]
  41. Maher P. Preventing and treating neurological disorders with the flavonol fisetin. Brain Plast. 2021 6 2 155 166 10.3233/BPL‑200104 33782648
    [Google Scholar]
  42. Ravula A.R. Teegala S.B. Kalakotla S. Pasangulapati J.P. Perumal V. Boyina H.K. Fisetin, potential flavonoid with multifarious targets for treating neurological disorders: An updated review. Eur. J. Pharmacol. 2021 910 174492 10.1016/j.ejphar.2021.174492 34516952
    [Google Scholar]
  43. Mehta P. Lohidasan S. Mahadik K.R. Pharmacokinetic behaviour of clinically important TCM prescriptions. Orient. Pharm. Exp. Med. 2017 17 3 171 188 10.1007/s13596‑017‑0281‑y
    [Google Scholar]
  44. Zhong R. Recent advances in the biosynthesis, structure–activity relationships, formulations, pharmacology, and clinical trials of fisetin e Food 2022 31 1-2 3
    [Google Scholar]
  45. Shanmugam K. Prem P.N. Boovarahan S.R. Sivakumar B. Kurian G.A. FIsetin preserves interfibrillar mitochondria to protect against myocardial ischemia-reperfusion injury. Cell Biochem. Biophys. 2022 80 1 123 137 10.1007/s12013‑021‑01026‑4 34392494
    [Google Scholar]
  46. Hassan S.S. The neuroprotective effects of fisetin, a natural flavonoid in neurodegenerative diseases: Focus on the role of oxidative stress. Front. Pharmacol. 2022 13 1015835
    [Google Scholar]
  47. Sahu B.D. Kalvala A.K. Koneru M. Mahesh Kumar J. Kuncha M. Rachamalla S.S. Sistla R. Ameliorative effect of fisetin on cisplatin-induced nephrotoxicity in rats via modulation of NF-κB activation and antioxidant defence. PLoS One 2014 9 9 e105070 10.1371/journal.pone.0105070 25184746
    [Google Scholar]
  48. Farooqi A.A. Naureen H. Zahid R. Youssef L. Attar R. Xu B. Cancer chemopreventive role of fisetin: Regulation of cell signaling pathways in different cancers. Pharmacol. Res. 2021 172 July 105784 10.1016/j.phrs.2021.105784 34302980
    [Google Scholar]
  49. Rengarajan T. Yaacob N.S. The flavonoid fisetin as an anticancer agent targeting the growth signaling pathways. Eur. J. Pharmacol. 2016 789 8 16 10.1016/j.ejphar.2016.07.001 27377217
    [Google Scholar]
  50. Kammerud S.C. Metge B.J. Elhamamsy A.R. Weeks S.E. Alsheikh H.A. Mattheyses A.L. Shevde L.A. Samant R.S. Novel role of the dietary flavonoid fisetin in suppressing rRNA biogenesis. Lab. Invest. 2021 101 11 1439 1448 10.1038/s41374‑021‑00642‑1 34267320
    [Google Scholar]
  51. Singh M. Mohapatra S. Harnessing the potential of phytochemicals for breast cancer treatment. In: Dietary Phytochemicals. Cham Springer 2021 223 251
    [Google Scholar]
  52. Maher P. How fisetin reduces the impact of age and disease on CNS function. Front. Biosci. -. Sch. 2015 7S 1 58 82 10.2741/s425
    [Google Scholar]
  53. Zheng L.T. Ock J. Kwon B.M. Suk K. Suppressive effects of flavonoid fisetin on lipopolysaccharide-induced microglial activation and neurotoxicity. Int. Immunopharmacol. 2008 8 3 484 494 10.1016/j.intimp.2007.12.012 18279803
    [Google Scholar]
  54. Behl T. Mehta K. Sehgal A. Singh S. Sharma N. Ahmadi A. Arora S. Bungau S. Exploring the role of polyphenols in rheumatoid arthritis. Crit. Rev. Food Sci. Nutr. 2022 62 19 5372 5393 10.1080/10408398.2021.1924613 33998910
    [Google Scholar]
  55. Ren Q. Cheng L. Guo F. Tao S. Zhang C. Ma L. Fu P. Fisetin improves hyperuricemia-induced chronic kidney disease via regulating gut microbiota-mediated tryptophan metabolism and aryl hydrocarbon receptor activation. J. Agric. Food Chem. 2021 69 37 10932 10942 10.1021/acs.jafc.1c03449 34505780
    [Google Scholar]
  56. Kim H.J. Kim S.H. Yun J.M. Fisetin inhibits hyperglycemia-induced proinflammatory cytokine production by epigenetic mechanisms. Evid. Based Complementary. Alternat. Med. 2012 2012 639469 10.1155/2012/639469
    [Google Scholar]
  57. Maher P. Dargusch R. Ehren J.L. Okada S. Sharma K. Schubert D. Fisetin lowers methylglyoxal dependent protein glycation and limits the complications of diabetes. PLoS One 2011 6 6 e21226 10.1371/journal.pone.0021226 21738623
    [Google Scholar]
  58. Jung C.H. Kim H. Ahn J. Jeon T.I. Lee D.H. Ha T.Y. Fisetin regulates obesity by targeting mTORC1 signaling. J. Nutr. Biochem. 2013 24 8 1547 1554 10.1016/j.jnutbio.2013.01.003 23517912
    [Google Scholar]
  59. Mohd Yusof Y.A. Gingerol and its role in chronic diseases. Advances in Experimental Medicine and Biology 2016 177 207 10.1007/978‑3‑319‑41342‑6_8
    [Google Scholar]
  60. Sundarraj K. Raghunath A. Perumal E. A review on the chemotherapeutic potential of fisetin: In vitro evidences. Biomed. Pharmacother. 2018 97 97 928 940 10.1016/j.biopha.2017.10.164 29136771
    [Google Scholar]
  61. Koneru M. Sahu B.D. Kumar J.M. Kuncha M. Kadari A. Kilari E.K. Sistla R. Fisetin protects liver from binge alcohol-induced toxicity by mechanisms including inhibition of matrix metalloproteinases (MMPs) and oxidative stress. J. Funct. Foods 2016 22 588 601 10.1016/j.jff.2016.02.019
    [Google Scholar]
  62. Zhang J. Zhao L. Hu C. Wang T. Lu J. Wu C. Chen L. Jin M. Hu H. Ji G. Cao Q. Jiang Y. Fisetin prevents acetaminophen-induced liver injury by promoting autophagy. Front. Pharmacol. 2020 11 February 162 10.3389/fphar.2020.00162 32184730
    [Google Scholar]
  63. Goh F.Y. Upton N. Guan S. Cheng C. Shanmugam M.K. Sethi G. Leung B.P. Wong W.S.F. Fisetin, a bioactive flavonol, attenuates allergic airway inflammation through negative regulation of NF-κB. Eur. J. Pharmacol. 2012 679 1-3 109 116 10.1016/j.ejphar.2012.01.002 22290391
    [Google Scholar]
  64. Higa S. Hirano T. Kotani M. Matsumoto M. Fujita A. Suemura M. Kawase I. Tanaka T. Fisetin, a flavonol, inhibits TH2-type cytokine production by activated human basophils. J. Allergy Clin. Immunol. 2003 111 6 1299 1306 10.1067/mai.2003.1456 12789233
    [Google Scholar]
  65. Hemanth Kumar B. Arun Reddy R. Mahesh Kumar J. Dinesh Kumar B. Diwan P.V. Effects of fisetin on hyperhomocysteinemia-induced experimental endothelial dysfunction and vascular dementia. Can. J. Physiol. Pharmacol. 2017 95 1 32 42 10.1139/cjpp‑2016‑0147 27901381
    [Google Scholar]
  66. Zhang L. Wang H. Zhou Y. Zhu Y. Fei M. Fisetin alleviates oxidative stress after traumatic brain injury via the Nrf2-ARE pathway. Neurochem. Int. 2018 118 February 304 313 10.1016/j.neuint.2018.05.011 29792955
    [Google Scholar]
  67. Kan E. Kiliçkan E. Ayar A. Çolak R. Effects of two antioxidants; α-lipoic acid and fisetin against diabetic cataract in mice. Int. Ophthalmol. 2015 35 1 115 120 10.1007/s10792‑014‑0029‑3 25488016
    [Google Scholar]
  68. Zakaria Z.A. Balan T. Suppaiah V. Ahmad S. Jamaludin F. Mechanism(s) of action involved in the gastroprotective activity of Muntingia calabura. J. Ethnopharmacol. 2014 151 3 1184 1193 10.1016/j.jep.2013.12.045 24380736
    [Google Scholar]
  69. Zhao X. Li X.L. Liu X. Wang C. Zhou D.S. Ma Q. Zhou W.H. Hu Z.Y. Antinociceptive effects of fisetin against diabetic neuropathic pain in mice: Engagement of antioxidant mechanisms and spinal GABAA receptors. Pharmacol. Res. 2015 102 286 297 10.1016/j.phrs.2015.10.007 26520392
    [Google Scholar]
  70. Zhao X. Wang C. Cui W.G. Ma Q. Zhou W.H. Fisetin exerts antihyperalgesic effect in a mouse model of neuropathic pain: Engagement of spinal serotonergic system. Sci. Rep. 2015 5 1 9043 10.1038/srep09043 25761874
    [Google Scholar]
  71. Lee Y. Bae E.J. Inhibition of mitotic clonal expansion mediates fisetin-exerted prevention of adipocyte differentiation in 3T3-L1 cells. Arch. Pharm. Res. 2013 36 11 1377 1384 10.1007/s12272‑013‑0226‑z 23918651
    [Google Scholar]
  72. Althunibat O.Y. Al Hroob A.M. Abukhalil M.H. Germoush M.O. Bin-Jumah M. Mahmoud A.M. Fisetin ameliorates oxidative stress, inflammation and apoptosis in diabetic cardiomyopathy. Life Sci. 2019 221 83 92 10.1016/j.lfs.2019.02.017 30742869
    [Google Scholar]
  73. Jin T. Kim O.Y. Shin M.J. Choi E.Y. Lee S.S. Han Y.S. Chung J.H. Fisetin up-regulates the expression of adiponectin in 3T3-L1 adipocytes via the activation of silent mating type information regulation 2 homologue 1 (SIRT1)-deacetylase and peroxisome proliferator-activated receptors (PPARs). J. Agric. Food Chem. 2014 62 43 10468 10474 10.1021/jf502849j 25286082
    [Google Scholar]
  74. Chamcheu J.C. Esnault S. Adhami V.M. Noll A.L. Banang-Mbeumi S. Roy T. Singh S.S. Huang S. Kousoulas K.G. Mukhtar H. Fisetin, a 3,7,3′,4′-tetrahydroxyflavone inhibits the PI3K/Akt/mTOR and MAPK pathways and ameliorates psoriasis pathology in 2D and 3D organotypic human inflammatory skin models. Cells 2019 8 9 1089 10.3390/cells8091089 31540162
    [Google Scholar]
  75. Kwon O. Eck P. Chen S. Corpe C.P. Lee J.H. Kruhlak M. Levine M. Inhibition of the intestinal glucose transporter GLUT2 by flavonoids. FASEB J. 2007 21 2 366 377 10.1096/fj.06‑6620com 17172639
    [Google Scholar]
  76. Shia C-S. Tsai S-Y. Kuo S-C. Hou Y-C. Chao P-D.L. Metabolism and pharmacokinetics of antihemolysis effects of fisetin and its serum metabolites. J. Agric. Food Chem. 2009 57 1 83 89 10.1021/jf802378q 19090755
    [Google Scholar]
  77. Krasieva T.B. Ehren J. O’Sullivan T. Tromberg B.J. Maher P. Cell and brain tissue imaging of the flavonoid fisetin using label-free two-photon microscopy. Neurochem. Int. 2015 89 243 248 10.1016/j.neuint.2015.08.003 26271433
    [Google Scholar]
  78. Singh S. Singh A.K. Garg G. Rizvi S.I. Fisetin as a caloric restriction mimetic protects rat brain against aging induced oxidative stress, apoptosis and neurodegeneration. Life Sci. 2018 193 171 179 10.1016/j.lfs.2017.11.004 29122553
    [Google Scholar]
  79. Lu W. Zhu J. Zou S. Li X. Huang J. The efficient expression of human fibroblast collagenase in Escherichia coli and the discovery of flavonoid inhibitors. J. Enzyme Inhib. Med. Chem. 2013 28 4 741 746 10.3109/14756366.2012.681650 22524676
    [Google Scholar]
  80. Pawar A Singh S Rajalakshmi S Shaikh K Bothiraja C Development of fisetin-loaded folate functionalized pluronic micelles for breast cancer targeting. Artif Cells Nanomed Biotechnol, 2018 46 sup1 347 361 10.1080/21691401.2018.1423991
    [Google Scholar]
  81. Jin M.J. Kim I.S. Rehman S.U. Dong M.S. Na C.S. Yoo H.H. A liquid chromatography-tandem mass spectrometry method for simultaneous quantitation of 10 bioactive components in rhus verniciflua extracts. J. Chromatogr. Sci. 2016 54 3 390 396 26499118
    [Google Scholar]
  82. Herrero-Martínez J.M. Oumada F.Z. Rosés M. Bosch E. Ràfols C. Determination of flavonoid aglycones in several food samples by mixed micellar electrokinetic chromatography. J. Sep. Sci. 2007 30 15 2493 2500 10.1002/jssc.200700124 17654618
    [Google Scholar]
  83. Jiang L. Fang G. Zhang Y. Cao G. Wang S. Analysis of flavonoids in propolis and Ginkgo biloba by micellar electrokinetic capillary chromatography. J. Agric. Food Chem. 2008 56 24 11571 11577 10.1021/jf802567r 19053353
    [Google Scholar]
  84. Kim S.A. Kim S.H. Kim I.S. Lee D. Dong M.S. Na C.S. Nhiem N.X. Yoo H.H. Simultaneous determination of bioactive phenolic compounds in the stem extract of Rhus verniciflua stokes by high performance liquid chromatography. Food Chem. 2013 141 4 3813 3819 10.1016/j.foodchem.2013.06.068 23993553
    [Google Scholar]
  85. Moolakkadath T. Aqil M. Imam SS. Ahad A. Praveen A. Sultana Y. Analytical quality by design (AQbD) approach based HPTLC method for quantification of fisetin with superior recovery in formulations. Curr. Anal. Chem. 2018 16 2 149 157
    [Google Scholar]
  86. SKA AL. Identification and determination of fisetin in black andgreen teas by ZIC-HILIC column coupled with UV detection. Sys Review Pharma 2021 12 2 289 294
    [Google Scholar]
  87. Bothiraja C. Yojana B.D. Pawar A.P. Shaikh K.S. Thorat U.H. Fisetin-loaded nanocochleates: Formulation, characterisation, in vitro anticancer testing, bioavailability and biodistribution study. Expert Opin. Drug Deliv. 2014 11 1 17 29 10.1517/17425247.2013.860131 24294925
    [Google Scholar]
  88. Padhi S. Dash M. Behera A. Nanophytochemicals for the treatment of type II diabetes mellitus: A review. Environ. Chem. Lett. 2021 19 6 4349 4373 10.1007/s10311‑021‑01283‑y
    [Google Scholar]
  89. Gupta V. Mohapatra S. Mishra H. Farooq U. Kumar K. Ansari M. Aldawsari M. Alalaiwe A. Mirza M. Iqbal Z. Nanotechnology in cosmetics and cosmeceuticals—a review of latest advancements. Gels 2022 8 3 173 10.3390/gels8030173 35323286
    [Google Scholar]
  90. Patnaik S. Gorain B. Padhi S. Choudhury H. Gabr G.A. Md S. Kumar Mishra D. Kesharwani P. Recent update of toxicity aspects of nanoparticulate systems for drug delivery. Eur. J. Pharm. Biopharm. 2021 161 100 119 10.1016/j.ejpb.2021.02.010 33639254
    [Google Scholar]
  91. Khalil N.M. Nascimento T.C.F. Casa D.M. Dalmolin L.F. Mattos A.C. Hoss I. Romano M.A. Mainardes R.M. Pharmacokinetics of curcumin-loaded PLGA and PLGA–PEG blend nanoparticles after oral administration in rats. Colloids Surf. B Biointerfaces 2013 101 353 360 10.1016/j.colsurfb.2012.06.024 23010041
    [Google Scholar]
  92. Khuroo T. Verma D. Talegaonkar S. Padhi S. Panda A.K. Iqbal Z. Topotecan–tamoxifen duple PLGA polymeric nanoparticles: Investigation of in vitro , in vivo and cellular uptake potential. Int. J. Pharm. 2014 473 1-2 384 394 10.1016/j.ijpharm.2014.07.022 25051112
    [Google Scholar]
  93. Ansari F. McGuiness C. Zhang B. Dauskardt R.H. Effect of emulsifiers on drying stress and intercellular cohesion in human stratum corneum. Int. J. Cosmet. Sci. 2020 42 6 581 589 10.1111/ics.12643 32567061
    [Google Scholar]
  94. Hu C. Wong W.T. Wu R. Lai W.F. Biochemistry and use of soybean isoflavones in functional food development. Crit. Rev. Food Sci. Nutr. 2020 60 12 2098 2112 10.1080/10408398.2019.1630598 31272191
    [Google Scholar]
  95. Kumar R. Kumar R. Khurana N. Singh S.K. Khurana S. Verma S. Sharma N. Kapoor B. Vyas M. Khursheed R. Awasthi A. Kaur J. Corrie L. Enhanced oral bioavailability and neuroprotective effect of fisetin through its SNEDDS against rotenone-induced Parkinson’s disease rat model. Food Chem. Toxicol. 2020 144 111590 10.1016/j.fct.2020.111590 32710995
    [Google Scholar]
  96. Ragelle H. Crauste-Manciet S. Seguin J. Brossard D. Scherman D. Arnaud P. Chabot G.G. Nanoemulsion formulation of fisetin improves bioavailability and antitumour activity in mice. Int. J. Pharm. 2012 427 2 452 459 10.1016/j.ijpharm.2012.02.025 22387278
    [Google Scholar]
  97. Seguin J. Brullé L. Boyer R. Lu Y.M. Ramos Romano M. Touil Y.S. Scherman D. Bessodes M. Mignet N. Chabot G.G. Liposomal encapsulation of the natural flavonoid fisetin improves bioavailability and antitumor efficacy. Int. J. Pharm. 2013 444 1-2 146 154 10.1016/j.ijpharm.2013.01.050 23380621
    [Google Scholar]
  98. Feng C. Yuan X. Chu K. Zhang H. Ji W. Rui M. Preparation and optimization of poly (lactic acid) nanoparticles loaded with fisetin to improve anti-cancer therapy. Int. J. Biol. Macromol. 2019 125 700 710 10.1016/j.ijbiomac.2018.12.003 30521927
    [Google Scholar]
  99. Ma P. Seguin J. Ly N.K. Henríquez L.C. Plansart E. Hammad K. Gahoual R. Dhôtel H. Izabelle C. Saubamea B. Richard C. Escriou V. Mignet N. Corvis Y. Designing fisetin nanocrystals for enhanced in cellulo anti-angiogenic and anticancer efficacy. Int. J. Pharm. X 2022 4 100138 10.1016/j.ijpx.2022.100138 36405872
    [Google Scholar]
  100. Ahn S.H. Ryu S.W. Choi H. You S. Park J. Choi C. Manufacturing therapeutic exosomes: From bench to industry. Mol. Cells 2022 45 5 284 290 10.14348/molcells.2022.2033 35534190
    [Google Scholar]
  101. Krishnan U.M. Biomaterials in the treatment of Parkinson’s disease. Neurochem. Int. 2021 145 105003 10.1016/j.neuint.2021.105003 33657427
    [Google Scholar]
  102. Ogawa M. Udono M. Teruya K. Uehara N. Katakura Y. Exosomes derived from fisetin-treated keratinocytes mediate hair growth promotion. Nutrients 2021 13 6 2087 10.3390/nu13062087 34207142
    [Google Scholar]
  103. Wang L. Zhang D.Z. Wang Y.X. Bioflavonoid fisetin loaded α-tocopherol-poly(lactic acid)-based polymeric micelles for enhanced anticancer efficacy in breast cancers. Pharm. Res. 2017 34 2 453 461 10.1007/s11095‑016‑2077‑z 28004315
    [Google Scholar]
  104. Dzakwan M. Pramukantoro G.E. Mauludin R. Wikarsa S. Formulation and characterization of fisetin nanosuspension. In: IOP Conference Series. Materials Science and Engineering 2017 10.1088/1757‑899X/259/1/012016
    [Google Scholar]
  105. Kulbacka J. Pucek A. Kotulska M. Dubińska-Magiera M. Rossowska J. Rols M.P. Wilk K.A. Electroporation and lipid nanoparticles with cyanine IR-780 and flavonoids as efficient vectors to enhanced drug delivery in colon cancer. Bioelectrochemistry 2016 110 19 31 10.1016/j.bioelechem.2016.02.013 26946158
    [Google Scholar]
  106. Crauste-Manciet S. Larquet E. Khawand K. Bessodes M. Chabot G.G. Brossard D. Mignet N. Lipidic spherulites: Formulation optimisation by paired optical and cryoelectron microscopy. Eur. J. Pharm. Biopharm. 2013 85 3 1088 1094 10.1016/j.ejpb.2013.02.016 23523544
    [Google Scholar]
  107. Ghosh P. Singha Roy A. Chaudhury S. Jana S.K. Chaudhury K. Dasgupta S. Preparation of albumin based nanoparticles for delivery of fisetin and evaluation of its cytotoxic activity. Int. J. Biol. Macromol. 2016 86 408 417 10.1016/j.ijbiomac.2016.01.082 26820351
    [Google Scholar]
  108. Jia S. Xu X. Zhou S. Chen Y. Ding G. Cao L. Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways. Cell Death Dis. 2019 10 2 142 10.1038/s41419‑019‑1366‑y 30760707
    [Google Scholar]
  109. Chen Y. Wu Q. Song L. He T. Li Y. Li L. Su W. Liu L. Qian Z. Gong C. Polymeric micelles encapsulating fisetin improve the therapeutic effect in colon cancer. ACS Appl. Mater. Interfaces 2015 7 1 534 542 10.1021/am5066893 25495760
    [Google Scholar]
  110. Sechi M. Syed D.N. Pala N. Mariani A. Marceddu S. Brunetti A. Mukhtar H. Sanna V. Nanoencapsulation of dietary flavonoid fisetin: Formulation and in vitro antioxidant and α-glucosidase inhibition activities. Mater. Sci. Eng. C 2016 68 594 602 10.1016/j.msec.2016.06.042 27524059
    [Google Scholar]
  111. Liu W.Y. Lin C.C. Hsieh Y.S. Wu Y.T. Nanoformulation development to improve the biopharmaceutical properties of fisetin using design of experiment approach. Molecules 2021 26 10 3031 10.3390/molecules26103031 34069585
    [Google Scholar]
  112. M., S. Novel PEGylated cholephytosomes for targeting fisetin to breast cancer: In vitro appraisal and in vivo antitumoral studies. Drug Deliv. Transl. Res. 2023 14 2 433 454
    [Google Scholar]
  113. Albash R. Yousry C. Al-Mahallawi A.M. Alaa-Eldin A.A. Utilization of PEGylated cerosomes for effective topical delivery of fenticonazole nitrate: In-vitro characterization, statistical optimization, and in-vivo assessment. Drug Deliv. 2021 28 1 1 9 10.1080/10717544.2020.1859000 33322971
    [Google Scholar]
  114. Kumar R. Khursheed R. Kumar R. Awasthi A. Sharma N. Khurana S. Kapoor B. Khurana N. Singh S.K. Gowthamarajan K. Wadhwani A. Self-nanoemulsifying drug delivery system of fisetin: Formulation, optimization, characterization and cytotoxicity assessment. J. Drug Deliv. Sci. Technol. 2019 54 101252 10.1016/j.jddst.2019.101252
    [Google Scholar]
/content/journals/cpb/10.2174/0113892010304479240415074928
Loading
Fisetin from Dietary Supplement to a Drug Candidate: An Assessment of Potential
Current Pharmaceutical Biotechnology 26, 1143 (2025); https://doi.org/10.2174/0113892010304479240415074928
/content/journals/cpb/10.2174/0113892010304479240415074928
/content/journals/cpb/10.2174/0113892010304479240415074928
Loading

Data & Media loading...

Supplements

Supplementary material is available on the publisher’s website along with the published article.

file format download Download

  • Article Type:     Review Article
Keyword(s): advanced drug delivery system; clinical trials; dietary supplement; Fisetin; patents; pharmacological properties

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test